Metabolic engineering of Escherichia coli for the production of neryl acetate

Zhen Zong,Suping Zhang,Menglin Zhen,Ning Xu,Dongsheng Li,Chao Wang,Bing Gao,Qiang Hua,Zhijie Liu
DOI: https://doi.org/10.1016/j.bej.2020.107704
IF: 3.9
2020-09-01
Biochemical Engineering Journal
Abstract:<p>Neryl acetate, a monoterpenoid derivate originated from neryl diphosphate (NPP), has found extensive applications in food, agriculture, and cosmetic fields. In this study, neryl acetate was biosynthesized in recombinant <em>Escherichia coli</em> for the first time. First, the alcohol acetyltransferase, ATF1, was heterologously expressed in a nerol-producing <em>E. coli</em> strain. The resultant engineered strain, LZ006, accumulated 0.250 ± 0.014 mg/L of neryl acetate. Further overexpression of tHMG1, which improved the metabolic flux of MVA pathway, enhanced the yield to 8.064 ± 0.724 mg/L in LZ007, representing a 32.2-fold increase compared to that of LZ006. Finally, supplementation with 2 g/L pyruvate in the culture further increased neryl acetate production to 11.712 ± 0.653 mg/L, representing a 46.8-fold increase over that of the LZ006 strain. This study provides a novel method for the biosynthesis of neryl acetate and the strategies described here could be adapted to biosynthesize many other NPP-derived bioproducts.</p>
engineering, chemical,biotechnology & applied microbiology
What problem does this paper attempt to address?